Outbreaks of Zika virus (ZIKV) disease have been recorded in Africa, the Americas, Asia, and the Pacific. The recent cluster of microcephaly cases and reports of neurological disorders in Brazil, following a similar cluster in French Polynesia in 2014, prompted the World Health Organization to declare Zika Virus Disease a Public Health Emergency of International Concern.

In the Philippines, 17 confirmed cases of ZIKV were documented in 2016 after the index case was identified in Iloilo on September 2, 2016. These cases did not have history of travel to an affected country a month prior to the onset of their illness. Due to this event, the Department of Health (DOH) issued a Department Memorandum No. 2016-0116 on February 22, 2016 providing technical guidelines, standards, and other Instructions for Reference in the Implementation of ZIKV Disease Surveillance amended on July 11, 2016 as Department Memorandum 0116-A. Also, DOH has been working on its advocacy to strengthen the 4S strategy against further Zika virus transmission in the country and in establishing clinical management guidelines.

The Research Institute for Tropical Medicine (RITM) in collaboration with the Disease Prevention and Control Bureau (DPCB), Epidemiology Bureau (EB), Health Promotion and Communication Services (HPCS) conducted a National Summit on Zika Virus Disease (ZIKV) with the theme “One Philippines Against Zika”, on October 28, 2016, 9AM, at the Forbes Ballroom 2 & 3 of the Conrad Hotel Manila, Mall of Asia Complex, Pasay City.

Representatives from DOH Regional Offices, government and private hospitals, Local Government Units, academe, allied professional societies, partner agencies and other concerned stakeholders, attended the event. The forum served as a venue to disseminate and discuss the DOH Zika Virus response and other relevant important topics for its prevention and control.
Click here to download the program.
Join the conversation! Use the hashtag: #OnePHAgainstZika


Global Epidemiology of Zika Virus Disease


Presented by Anthony Eshofonie, MD of the WHO-WPRO

Iloilo City Zika Experience


Presented by Bernard L. Caspe, MD, FPAFP, MMPM, MBA of Iloilo City Health Office

Zika Virus Disease: Clinical Presentation and Management among Non-pregnant Adults and Children


Presented by Arthur Dessi E. Roman, MD, MTM, FPCP, FPSMID of RITM

ZIKV infection in Pregnancy


Presented by Ricardo M. Manalastas Jr., MD of UP-PGH

ZIKV Associated Neurologic Disorders


Presented by Aida M. Salonga, MD of UP-PGH

Zika Virus Surveillance in the Philippines


Presented by Genesis May J. Samonte, MD, MSc, PHSAE of the DOH Epidemiology Bureau

Laboratory Diagnosis of Zika Virus Infection


Presented by Amado O. Tandoc III, MD, FPSP of RITM

Vector Surveillance and Control


Presented by Ferdinand V. Salazar, PhD of RITM